Gene Query: MLH3

Dataset Description Geneva Score
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 19.79
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 17.45
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 16.14
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 15.51
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 13.34
Differentially expressed genes post knock down of lincDUSP26 12.22
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 11.91
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 11.87
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 11.67
RNA sequencing of primary human platelets and in vitro cell lines 11.64
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 10.92
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 10.88
Cellular response to hepatitis E virus (HEV) infection 10.12
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 9.29
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 9.08
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 9.08
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 9.0
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 8.98
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 8.49
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 8.05
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 7.75
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 7.18
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 6.9
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 6.9
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 6.9
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 6.87
MYC dependent mRNA translation shapes gene expression and cell biology 6.67
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 6.67
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 6.32
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 6.31
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 6.19
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 6.18
RNA-sequencing of formalin fixed human primary melanoma tissue 6.17
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 6.16
The evolution of N6-methyladenosine in primates 6.06
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 6.04
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 5.98
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 5.94
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 5.87
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 5.82
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 5.73
RNA-seq data from human lymphoma cell lines 5.63
ChIP-seq and RNA-seq from human lymphoma cell lines 5.63
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 5.59
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 5.36
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 5.31
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 5.24
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 5.06
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 5.05
Gene expression in PANC1 cells treated with Rakicidin 5.04
Single-Cell Genotyping of Transcriptomes 4.99
RNA-seq of Single-Cell Genotyping of Transcriptomes 4.99
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 4.96
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 4.87
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 4.87
NRDE2 negatively regulates nuclear exosome functions 4.86
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 4.85
LNCaP treated with iBET 4.83
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 4.82
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 4.82
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 4.74
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 4.73
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 4.72
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 4.69
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 4.63
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 4.62
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 4.53
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 4.49
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 4.48
AR-independent prostate cancer is sustained through FGF signaling 4.42
RNAseq Analysis in glioblastoma cells treated with Mepazine 4.38
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 4.36
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 4.33
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 4.3
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 4.3
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 4.26
N6-methyladenine DNA Modification in Glioblastoma 4.2
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 4.2
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 4.18
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 4.16
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 4.14
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 4.11
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 4.08
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 4.07
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 4.06
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 4.05
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 4.05
Identification of transcription start sites for human A549 cell line using ReCappable-seq 4.02
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 3.98
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 3.98
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 3.96
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 3.96
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 3.96
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 3.95
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 3.93
Accurate annotation of human protein-coding small open reading frames 3.92
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 3.84
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 3.83
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 3.81
RNA-seq of YB5 cells treated with Proscillaridin A 3.76
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 3.75
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 3.71
Effect of PBK knockdown on C4-2 cell transcriptome 3.7
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 3.68
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 3.67
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 3.67
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 3.66
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 3.66
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 3.65
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 3.65
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 3.63
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 3.63
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 3.6
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 3.57
Identification of long noncoding RNAs regulated by p53 3.56
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 3.53
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 3.53
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 3.52
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 3.52
A prostate cancer chromatin interaction map 3.48
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 3.46
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 3.45
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 3.43
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 3.43
Intron retention induced by microsatellite expansions as a disease biomarker. 3.42
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 3.41
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 3.41
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 3.41
Hypoxic transcriptome of SQ20B human head and neck cancer cells 3.41
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 3.4
The pause-initiation limit restricts transcription activation in human cells 3.4
Total RNA-seq in ALL-SIL upon JQ1 inhibition 3.34
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 3.33
TGF-β regulation of miRNA expression in pancreatic cancer 3.29
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 3.28
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 3.24
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 3.24
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 3.24
RNA-seq melanoma 3.22
Transcriptome of EBV-infected gastric cancer cell lines 3.21
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 3.21
Gene expression profile in breast cancer cells 3.21
4sUDRB-seq: measuring transcription elongation and initiation genomewide 3.16
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 3.14
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 3.14
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 3.13
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 3.13
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 3.13
Developmental stage specific chromosome architecture in human erythroid cells 3.13
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 3.13
SRSF2 mutations impair hematopoiesis and alter exon recognition 3.09
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 3.07
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 3.04
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 3.04
Total RNA-seq in ALL-SIL upon TLX1 knockdown 3.03
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 3.03
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 3.03
Peptidomimetic blockade of MYB in acute myeloid leukemia 3.02
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 3.02
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 3.01
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 2.99
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 2.99
MeRIP-seq for heat shock in B-cell lymphoma cells 2.98
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 2.96
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 2.94
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 2.92
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 2.92
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 2.91
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 2.9
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 2.9
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 2.88
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 2.87
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 2.87
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 2.87
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 2.87
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 2.86
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 2.82
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 2.82
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 2.8
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 2.79
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 2.78
RNA seq comparison between scrambled and shGRP78 cells 2.77
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 2.77
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 2.77
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 2.73
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 2.72
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 2.71
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 2.7
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 2.69
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 2.69
Gene expression in GBM with Cav3.2 inhibition 2.67
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 2.67
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 2.66
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 2.66
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 2.65
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 2.65
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 2.65
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 2.62
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 2.61
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 2.61
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 2.61
Transcriptional profiling of LS1034 cells treated with tepoxalin 2.61
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 2.61
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 2.59
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 2.59
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 2.59
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 2.58
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 2.58
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 2.57
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 2.55
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 2.54
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 2.52
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 2.52
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 2.52
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 2.52
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 2.48
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 2.48
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 2.48
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 2.48
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 2.48
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 2.47
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 2.47
Discovering human diabetes-risk gene function with genetics and physiological assays 2.45
RNA-sequencing of human tendon after injury 2.42
BASP1 modifies the Tamoxifen response 2.4
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 2.36
DRB/GRO-Seq -/+ UV 2.34
RNA-sequencing 2.34
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 2.33
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 2.33
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 2.32
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 2.32
Gene expression analysis in response to hypoxic pathway inhibition 2.31
Transcriptome analysis of H9 hESC derived cerebral organoids 2.31
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 2.3
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 2.3
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 2.3
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 2.24
LncRNA expression profiling of ischemic stroke patients 2.24
Identification of Atrial Fibrillation associated genes and functional non-coding variants 2.23
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 2.22
ARS2 is a general suppressor of pervasive transcription [RNAseq] 2.2
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 2.19
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 2.19
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 2.18
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 2.18
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 2.16
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 2.16
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 2.16
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 2.12
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 2.12
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 2.11
Global gene expression profile of dasatinib-resistant RCH-ACV cells 2.1
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 2.09
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 2.09
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 2.07
RNAseq of T-ALL upon long non coding rna purturbation 2.06
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 2.05
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 2.03
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 2.03
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 2.02
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 2.02
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 2.02
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 2.0
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 1.99
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 1.98
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 1.95
1.95
RNA sequencing of human mammary epithelial cells 1.95
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 1.93
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 1.93
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 1.93
Effect of PRDM11 depletion in U2932 cells 1.92
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 1.91
RNAseq analysis of ruxolitinib treated breast cancers 1.9
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 1.88
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 1.87
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 1.86
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 1.82
RNAseq Study in CC-671 Treated Cal-51 Cells 1.82
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 1.82
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 1.81
Capturing the Interactome of Newly Transcribed RNA (RICK) 1.81
Capturing the Interactome of Newly Transcribed RNA 1.81
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 1.81
Identification of long noncoding RNAs in T-ALL cell lines 1.79
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 1.77
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 1.76
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 1.76
Transcriptional profiling of microglia; current state of the art and future perspectives 1.76
Landscape and variation of RNA secondary structure across the human transcriptome 1.74
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 1.73
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 1.72
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 1.71
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 1.7
Transcriptome landscape of HeLa response upon triamcinolone acetonide 1.7
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 1.67
RNA polymerase in pre-B-ALL cell lines 1.66
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 1.66
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 1.62
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 1.61
Transcriptional landscape changes during human embryonic stem cell derivation 1.61
Single-cell analysis of human kidney organoids 1.61
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 1.6
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 1.58
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 1.57
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 1.56
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 1.56
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.54
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 1.52
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 1.52
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 1.5
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 1.46
mRNA recovered upon RNF219 IP. [RNA-IP] 1.44
Effect of drugs on transcriptomic profiles 1.39
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 1.39
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 1.38
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 1.34
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 1.34
Single cell transcriptome of peritoneal cells 1.33
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 1.31
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 1.3
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 1.28
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 1.27
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 1.26
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 1.24
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 1.24
Transcriptome Profiling of Human Primary Monocytes 1.22
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 1.21
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 1.2
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 1.18
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.16
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.14
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 1.13
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 1.12
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 1.1
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 1.1
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 1.07
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 1.05
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 1.05
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 1.04
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 1.04
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 1.04
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 1.04
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 1.04
RNA sequencing analysis of selumetinib-resistant CRC cells lines 1.03
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 1.01
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 1.01
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 1.01
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 1.01
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 1.0
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 0.99
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 0.98
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 0.98
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.97
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 0.96
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 0.95
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 0.95
Deep RNA sequencing of the human placental transcriptome 0.95
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 0.95
Myc activation coordinates gene transcription and protein translation responses 0.95
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 0.94
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 0.94
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 0.94
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 0.93
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 0.93
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 0.92
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 0.9
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 0.89
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 0.89
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 0.89
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 0.87
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 0.87
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 0.87
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.87
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 0.87
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 0.86
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 0.86
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 0.85
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 0.85
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 0.83
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 0.83
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 0.83
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 0.83
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 0.83
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 0.82
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 0.82
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 0.8
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.79
High-resolution comparative analysis of great ape genomes 0.79
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 0.77
The MEF2B Regulatory Network - RNA-seq data 0.77
The MEF2B Regulatory Network 0.77
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.76
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 0.75
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 0.75
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 0.75
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 0.74
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 0.74
The transcriptome of Kawasaki Disease arteritis 0.74
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 0.73
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.72
Gene expression analysis of human hepatocellular cancers 0.7
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.69
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 0.69
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 0.68
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 0.68
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 0.67
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 0.66
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 0.65
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 0.65
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 0.64
Mesothelioma xenografts in nude mice: PBS treated versus pirfenidone treated 0.63
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 0.62
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.6
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 0.6
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 0.58
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 0.57
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 0.57
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 0.57
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 0.57
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 0.56
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.55
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.55
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 0.55
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 0.54
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.54
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.54
Human ovarian granulosa cell transcriptome 0.53
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 0.53
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 0.52
Widespread intronic polyadenylation diversifies immune cell transcriptomes 0.52
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.51
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.51
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 0.51
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 0.5
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 0.49
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.48
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 0.46
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 0.46
SF3B1 Degron knockdown RNA-seq 0.46
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 0.45
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 0.43
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.39
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.39
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 0.39
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 0.38
Modeling Human Cancer-induced Cachexia (Human) 0.37
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.37
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.37
Gene expression analysis of human adenomas. 0.36
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 0.35
RNA-seq analysis of control and Myc-induced U2OS cells 0.33
An siRNA screen identifies CHD4 as a target for epigenetic therapy 0.33
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 0.32
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.32
Ribosomal protein RPL26 is the principal target of UFMylation 0.32
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.31
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 0.31
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 0.31
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.3
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 0.29
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 0.26
Transcriptomes in healthy and CHB fetal hearts 0.26
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.26
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 0.25
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 0.25
RNA-Seq from human ILC transitional populations 0.25
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 0.24
The landscape of alternative splicing in aggressive prostate cancers 0.23
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.21
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.21
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 0.19
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 0.18
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 0.18
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 0.17
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 0.16
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.16
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.15
Transcriptome-wide modulation of splicing by the exon junction complex 0.15
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 0.14
Gene expression profile of human placenta from T. Cruzi infected mothers 0.13
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.13
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.12
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 0.12
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 0.12
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 0.12
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 0.11
Function and hormonal regulation of GATA3 in human first trimester placentation 0.11
hNSCs siRNA NOVA2 0.1
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.09
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 0.09
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 0.07
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. 0.07
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. 0.07
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 0.06
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 0.04
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.03
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.03
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation